Boston Scientific has today announced a €30m investment in its Cork facility which will create more than 70 new engineering and production jobs over the next three years.
The research, development, and innovation investment is supported by IDA Ireland.
Boston Scientific’s Cork site currently employs more than 1,200 people and makes medical devices for interventional oncology, coronary artery disease, digestive disorders and severe asthma.
It said the new investment will accelerate the development and manufacturing of minimally-invasive medical technologies that treat patients suffering from cancer and peripheral arterial diseases around the world.
Boston Scientific first came to Ireland in 1994 and today is the largest life sciences employer in Ireland.
With a workforce of more than 6,000 people across three locations at Galway, Clonmel and Cork, the company exports more than 12 million medical devices annually.
“We are delighted to be adding new quality, engineering and production capabilities to our Cork facility and contributing further to the strong MedTech sector in the region,” said Sean Gayer, vice president operations at Boston Scientific, Cork.
Tánaiste and Minister for Enterprise, Trade & Employment Leo Varadkar said today’s investment will allow the company to grow and develop its world leading technologies and ensure that it continues helping to improve and save lives.
“Ireland is globally recognised as a centre of excellence for the Life Sciences and this investment is a real vote of confidence in us and our capacity,” he added.
Credit: Source link
